nPOD病毒组数据联合分析:多种胰腺组织感染标志物支持肠道病毒与1型糖尿病的关联
nPOD病毒组对2007至2019年间197名供者的胰腺进行多种肠道病毒标志物检测,发现1型糖尿病伴残存胰岛素包含胰岛组阳性比例最高(58.4%),显著高于其他各组,且多种独立检测方法重复性高,提示胰腺肠道病毒感染可能参与β细胞丢失。
要点
- 1型糖尿病伴残存胰岛素包含胰岛供者多种肠道病毒标志物阳性比例显著高于其他组。
- 多种独立实验室检测方法重复性高,支持肠道病毒感染与1型糖尿病的关联。
- 感染细胞少、病毒RNA量低,提示胰腺中可能存在非急性、低水平、持续性的肠道病毒感染。
核心结论
- nPOD病毒组迄今开展了针对1型糖尿病胰腺肠道病毒感染多种指标的最大规模、最全面的分析。
- 这些指标在T1D-ICI和AAb++供者中比其他组更常见。
- 在残存β细胞和自身免疫的供者中优先检测到这些指标,提示肠道病毒感染贯穿疾病进展阶段,并支持其直接或间接参与β细胞丢失,甚至诊断后仍可能起作用。
- 感染细胞数量少和病毒RNA量低支持胰腺中存在非急性、低水平、可能持续性的肠道病毒感染。
研究设计与样本
- nPOD病毒组分析了2007至2019年间回收的197名供者的胰腺,分为五组:T1D-ICI组(n=41)、T1D-IDI组(n=42)、ND组(n=83)、AAb+组(n=22)和AAb++组(n=9)。
- 对197名nPOD供者共进行了645次检测,使用多种统计方法逐一病例及组间评估多种肠道病毒感染指标的整体关联、检测方法一致性和重复性。
主要发现
- 独立实验室检测肠道病毒指标的重复性高,使用肠道病毒靶向和无偏方法均如此。
- T1D-ICI供者阳性检测结果比例(58.4%)显著高于T1D-IDI(10.3%)、ND(17.8%)和AAb阳性供者(AAb+ 24.6%;AAb++ 35.0%),p<0.001。
- 头对头比较显示,T1D-ICI vs ND供者在两种独立检测中阳性的比例增加:VP1/HLA-I,p<0.0001;VP1/EV-PCR,p=0.076;EV-PCR/HLA-I,p=0.016;蛋白质组学/HLA-I,p<0.0001;VP1/蛋白质组学,p=0.06。
- 在110名检测三种标志物(VP1、EV-PCR和HLA-I)的供者中,83.3%的T1D-ICI供者在两种或以上检测中阳性,而ND为0%(p<0.001)、AAb+为26.7%(p=0.006)、AAb++为28.6%(p=0.023)、T1D-IDI为0%(p<0.001)。
局限性
- 感染细胞数量相对较少,病毒RNA量低,支持胰腺中存在非急性、低水平、可能持续性的肠道病毒感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Previous pathology studies have associated enterovirus infections with type 1 diabetes by examining the enterovirus capsid protein 1 (VP1) in autopsy pancreases obtained near diabetes diagnosis. The Network for Pancreatic Organ Donors with Diabetes (nPOD) has since obtained pancreases from organ donors with type 1 diabetes (with broad age and disease duration) and donors with disease-associated autoantibodies (AAbs), the latter representing preclinical disease. Two accompanying manuscripts from the nPOD-Virus Group report primary data from a coordinated analysis of multiple enterovirus indices. We aimed to comprehensively assess the association of multiple enterovirus markers with type 1 diabetes. METHODS: The nPOD-Virus Group examined pancreases from 197 donors, recovered between 2007 and 2019, classified into five groups: donors with type 1 diabetes, with residual insulin-containing islets (T1D-ICI group, n=41) or with only insulin-deficient islets (T1D-IDI, n=42); donors without diabetes who are AAb-negative (ND, n=83); and rare donors without diabetes expressing a single AAb (AAb+, n=22) or multiple AAbs (AAb++, n=9). We assessed the overall association of multiple indicators of enterovirus infection, case-by-case and between donor groups, as well as assay agreement and reproducibility, using various statistical methods. We examined data from 645 assays performed across 197 nPOD donors. RESULTS: Detection of enterovirus indices by independent laboratories had high reproducibility, using both enterovirus-targeted and unbiased methods. T1D-ICI donors had significantly higher (p<0.001) proportions of positive assay outcomes (58.4%) vs T1D-IDI (10.3%), ND (17.8%) and AAb-positive donors (AAb+ 24.6%; AAb++ 35.0%). Head-to-head comparisons revealed increased proportions of donors positive in two independent assays among T1D-ICI vs ND donors (VP1/HLA class I [HLA-I], p<0.0001; VP1/enterovirus-specific RT-PCR (EV-PCR), p=0.076; EV-PCR/HLA-I, p=0.016; proteomics/HLA-I, p<0.0001; VP1/proteomics, p=0.06). Among 110 donors examined for three markers (VP1, EV-PCR and HLA-I), 83.3% of T1D-ICI donors were positive in two or more assays vs 0% of ND (p<0.001), 26.7% of AAb+ (p=0.006), 28.6% of AAb++ (p=0.023) and 0% of T1D-IDI (p<0.001) donors. CONCLUSIONS/INTERPRETATION: The nPOD-Virus Group conducted, to date, the largest and most comprehensive analysis of multiple indices of pancreatic enterovirus infections in type 1 diabetes; these were more prevalent in T1D-ICI and AAb++ donors than in other groups. Their preferential detection of these indices in donors with residual beta cells and autoimmunity implicates enterovirus infections across disease progression stages and supports a contribution to beta cell loss, directly or indirectly, even after diagnosis. The relatively small number of infected cells and the low amount of viral RNA support the existence of non-acute, low level, possibly persistent enterovirus infections in the pancreas.
引用
- Richardson SJ, Rodriguez-Calvo T, Laiho JE, et al. Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue. Diabetologia. 2025. PMID: 40090994. doi:10.1007/s00125-025-06401-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。